The latest Investing Matters Podcast with Jean Roche, Co-Manager of Schroder UK Mid Cap Investment Trust has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksDeltex Medical Regulatory News (DEMG)

Share Price Information for Deltex Medical (DEMG)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 0.115
Bid: 0.11
Ask: 0.12
Change: 0.00 (0.00%)
Spread: 0.01 (9.091%)
Open: 0.115
High: 0.115
Low: 0.115
Prev. Close: 0.115
DEMG Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Holding(s) in Company

28 Mar 2017 18:05

RNS Number : 8115A
Deltex Medical Group PLC
28 March 2017
 

TR-1: NOTIFICATION OF MAJOR INTEREST IN SHARES

1. Identity of the issuer or the underlying issuerof existing shares to which voting rights areattached:

 

Deltex Medical Group Plc

2. Reason for the notification (please tick the appropriate box or boxes):

An acquisition or disposal of voting rights

 

An acquisition or disposal of qualifying financial instruments which may result in the acquisition of shares already issued to which voting rights are attached.

 

 

An acquisition or disposal of instruments with similar economic effect to qualifying financial instruments

 

An event changing the breakdown of voting rights

Yes

 

Other (please specify):

 

3. Full name of person(s) subject to thenotification obligation:

Legal & General Group Plc

 

Legal & General Investment Management Limited (LGIM)

4. Full name of shareholder(s)  (if different from 3.):

 

 

Legal & General Assurance Society Limited (LGAS)

 

 

5. Date of the transaction and date onwhich the threshold is crossed orreached:

 

27 March 2017

6. Date on which issuer notified:

28 March 2017

7. Threshold(s) that is/are crossed orreached:

 

 

 

LGIM (Below 5%)

 

 

 

8. Notified details:

 

A: Voting rights attached to shares

Class/type ofshares

if possible usingthe ISIN CODE

Situation previousto the triggeringtransaction

Resulting situation after the triggering transaction

NumberofShares

NumberofVotingRights

 

Numberof shares

Number of votingrights

% of voting rights

Direct

Indirect

Direct

Indirect

GBP 0.01

 

LGIM

 

 14,418,386

 

 

 Below 5%

Below 5%

Below 5%

B: Qualifying Financial Instruments

Resulting situation after the triggering transaction

 

Type of financialinstrument

 

Expirationdate

 

Exercise/Conversion Period

Number of votingrights that may beacquired if theinstrument isexercised/ converted.

 

% of votingrights

C: Financial Instruments with similar economic effect to Qualifying Financial Instruments

Resulting situation after the triggering transaction

 

Type of financialinstrument

 

 

Exercise price

 

Expiration date

 

Exercise/Conversion period

 

Number of voting rights instrument refers to

 

 

% of voting rights

 

 -

 

Nominal

Delta

 

 

 

 

 

Total (A+B+C)

Number of voting rights

Percentage of voting rights

 

(LGIM)

 

 Below 5%

 

 

9. Chain of controlled undertakings through which the voting rights and/or thefinancial instruments are effectively held, if applicable:

 

Legal & General Group Plc (Direct and Indirect) (Group) (Below 5% = Total Position)

Legal & General Investment Management (Holdings) Limited (LGIMH) (Direct and Indirect) (Below 5% = Total Position)

Legal & General Investment Management Limited (Indirect) (LGIM) (Below 5% = Total Position)

Legal & General (Unit Trust Managers) Limited (Below 5% = UTM)

Legal & General Group Plc (Direct) (L&G) (Below 3% -=LGAS & PMC)

Legal & General Investment Management (Holdings) Limited (Direct) (LGIMHD)

Legal & General Insurance Holdings Limited (Direct) (LGIH)

Legal & General Assurance (Pensions Management) Limited (PMC)

Legal & General Assurance Society Limited (LGAS)

Proxy Voting:

10. Name of the proxy holder:

N/A

11. Number of voting rights proxy holder will ceaseto hold:

N/A

12. Date on which proxy holder will cease to holdvoting rights:

N/A

13. Additional information:

Notification using the total voting rights figure of 296,631,733

 

14. Contact name:

Victoria Davies (LGIM)

15. Contact telephone number:

029 2035 4147

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
HOLEAKDPASNXEFF
Date   Source Headline
25th Sep 20177:00 amRNSShare Options
21st Sep 20177:00 amRNSRelease and first sale of HD-ICG in France
11th Sep 20177:00 amRNSInterim Results
31st Aug 20177:00 amRNSNotice of Interim Results
31st Aug 20177:00 amRNSInvestor Event
2nd Aug 201712:59 pmRNSHolding(s) in Company
28th Jul 201711:10 amRNSHolding(s) in Company
27th Jul 20175:24 pmRNSHolding(s) in Company
21st Jul 20177:01 amRNSShare placing
21st Jul 20177:00 amRNSPre-close Trading Update
13th Jun 20179:30 amRNSDirector/PDMR Shareholding
9th Jun 20171:25 pmRNSResult of AGM
9th Jun 20177:00 amRNSExcellent Results from New Trial
9th Jun 20177:00 amRNSAGM Statement
31st May 20177:00 amRNSPatent Grant
26th May 20177:00 amRNSLaunch of ODMV+ system for veterinary anaesthesia
4th May 20177:00 amRNSNew Functionality on CardioQ-ODM+ Monitor Platform
3rd May 20172:20 pmRNSExercise of Options
3rd May 20172:15 pmRNSPublication of Annual Report & Notification of AGM
27th Apr 20177:01 amRNSDeltex awarded EU Horizon 2020 Phase 1 grant
27th Apr 20177:00 amRNSResults for the year ended 31 December 2016
20th Apr 201712:25 pmRNSInvestor open day and notice of results
4th Apr 201711:51 amRNSExercise of Options
28th Mar 20176:05 pmRNSHolding(s) in Company
22nd Mar 20177:15 amRNSGrant of Options
22nd Mar 20177:00 amRNSShare Issues
23rd Feb 20177:00 amRNSNew Monitor Sales in USA and UK
25th Jan 20177:00 amRNSSouth Korean broadens ODM reimbursement
18th Jan 20177:00 amRNSTwo additional US platform programme accounts
18th Jan 20177:00 amRNSTrading Update
30th Nov 20167:00 amRNSAdditional US platform programme account
4th Nov 20167:00 amRNSNHS hospital invests in ODM equipment
8th Sep 20167:00 amRNSThree new US platform programme accounts
8th Sep 20167:00 amRNSInterim results
15th Aug 201611:10 amRNSHolding(s) in Company
15th Jul 20164:00 pmRNSHolding(s) in Company
11th Jul 20167:00 amRNSResults from head to head trial presented
8th Jul 20167:00 amRNSPre-close Trading Update
1st Jul 20168:19 amRNSShare Subscription
17th Jun 20164:10 pmRNSDirector/PDMR Shareholding
9th Jun 20167:00 amRNSTwo new accounts added to US platform programme
1st Jun 20167:00 amRNSODM adopted into clinical guidelines in Spain
12th May 20161:10 pmRNSResult of AGM
12th May 20169:30 amRNSDirector/PDMR Shareholding
12th May 20167:01 amRNSTwo US accounts added to platform programme
12th May 20167:00 amRNSAGM Statement
4th May 20167:00 amRNSEnhanced performance TruFlow probe launched in UK
20th Apr 20163:25 pmRNSPosting of Annual Report and Notice of AGM
5th Apr 20167:00 amRNSTwo new US platform programme accounts opened
10th Mar 20167:00 amRNSPlacing and Issue of Shares

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.